Amplyx Pharmaceuticals competitors

Amplyx Pharmaceuticals Competitors include Roche, Novartis, GlaxoSmithKline and Bristol-Myers Squibb.
Add company...
Roche
Roche Holding is a diagnostics and pharmaceutical company.
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Founding Date
Founding Date
2006
Founding Date
1896
Founding Date
1996
Founding Date
2000
Founding Date
1887
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Basel, CH HQ
South San Francisco, US
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
Brentford, GB HQ
Locations
New York, US HQ
Lawrence Township, US
Bi, DE
Zug, CH
Braine L'alleud, BE
Hopewell, US
Devens, US
see more
Employees
Employees
284% increase
Employees
93,734
Employees
126,0004% increase
Employees
98,462
Employees
23,700
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
175.5 b
Valuation ($)
101.9 b
Valuation ($)
85.8 b
Facebook likes
Facebook likes
N/A
Facebook likes
80.2 k
Facebook likes
304.3 k
Facebook likes
273 k
Facebook likes
120.2 k
Twitter followers
Twitter followers
N/A
Twitter followers
177.2 k
Twitter followers
234.4 k
Twitter followers
163.4 k
Twitter followers
120.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
£30.2b (FY, 2017)
Revenue (est.)
$20.8b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
$17.2b (FY, 2017)
Cost of goods
£10.3b (FY, 2017)
Cost of goods
$6.1b (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
CHF32.7b (FY, 2015)
Gross profit
$31.9b (FY, 2017)
Gross profit
£19.8b (FY, 2017)
Gross profit
$14.7b (FY, 2017)
Net income
Net income
N/A
Net income
CHF9.1b (FY, 2015)
Net income
$7.7b (FY, 2017)
Net income
£2.2b (FY, 2017)
Net income
$975m (FY, 2017)

Operating

Major Approvals (US, EU, JP)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
12 (Y, 2016)
Major Approvals (US, EU, JP)
16 (Y, 2016)
Major Approvals (US, EU, JP)
N/A
Major Approvals (US, EU, JP)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
8 (FY, 2016)
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
5 (Y, 2016)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A

Funding

Total funding raised
Total funding raised
$ 116.2m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
$ 15.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Roche
HQ
Basel, CH
Employees
93,734

Roche Holding is a diagnostics and pharmaceutical company.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
23,700

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company